Clinical trials
Uterine Cervical Dysplasia trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
52 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 2 |
| 2015 | 4 |
| 2016 | 3 |
| 2017 | 5 |
| 2018 | 7 |
| 2019 | 2 |
| 2020 | 5 |
| 2021 | 5 |
| 2022 | 5 |
| 2023 | 1 |
| 2024 | 6 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 22 |
| Completed | 18 |
| Not yet recruiting | 5 |
| Active, not recruiting | 4 |
| Enrolling by invitation | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Huazhong University of Science and Technology | 5 |
| Jun Zhang | 5 |
| Lei Li | 5 |
| Xiamen University | 4 |
| GlaxoSmithKline | 3 |
| Shanghai Zerun Biotechnology Co.,Ltd | 3 |
| First Hospital of China Medical University | 2 |
| Peking University People's Hospital | 2 |
| Preventive Oncology International, Inc. | 2 |
| Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Uterine Cervical Dysplasia | 52 |
| Uterine Cervical Neoplasms | 30 |
| Papillomavirus Infections | 12 |
| Persistent Infection | 9 |
| Squamous Intraepithelial Lesions | 8 |
| Adenocarcinoma in Situ | 2 |
| Atypical Squamous Cells of the Cervix | 2 |
| Neoplasms | 2 |
| Bowen's Disease | 1 |
| Condylomata Acuminata | 1 |
Trials
Showing 51 to 52 of 52. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.